Catalyst Wire Dossier Catalyst Wire Dossier

ExPEC4V

JNJ-63871860 · Janssen Pharmaceuticals K.K.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ExPEC4V, covering 2016-10-04 to 2019-11-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety and Immunogenicity of the ExPEC4V Clinical Trial Material After a Single Intramuscular Dose and a Second Dose 6 Months Later in Healthy Participants Aged 18 Years and Older [Phase 2]

See pricing